 | • レポートコード：MRC-IM30134 • 出版社/出版日：IMARC / 2022年10月 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥349,860 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥629,860 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年50億ドルであった世界のコンパニオン診断市場規模が2027年には117億ドルに達し、予測期間中、年平均14.78％成長すると予測しています。本調査レポートでは、コンパニオン診断の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品・サービス別（アッセイ・キット・試薬、ソフトウェア・サービス）分析、技術別（免疫組織化学（IHC）、ポリメラーゼ連鎖反応（PCR）、in situハイブリダイゼーション（ISH）、リアルタイムPCR（RT-PCR）、その他）分析、疾患別（がん、神経疾患、感染症、心血管疾患、その他）分析、エンドユーザー別（医薬品・バイオ医薬品企業、参考検査室、受託研究機関、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcareなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のコンパニオン診断市場規模：製品・サービス別 - コンパニオン診断アッセイ・キット・試薬の市場規模 - コンパニオン診断ソフトウェア・サービスの市場規模 ・世界のコンパニオン診断市場規模：技術別 - 免疫組織化学（IHC）法コンパニオン診断の市場規模 - ポリメラーゼ連鎖反応（PCR）法コンパニオン診断の市場規模 - in situハイブリダイゼーション（ISH）法コンパニオン診断の市場規模 - リアルタイムPCR（RT-PCR）法コンパニオン診断の市場規模 - その他コンパニオン診断の市場規模 ・世界のコンパニオン診断市場規模：疾患別 - がんにおける市場規模 - 神経疾患における市場規模 - 感染症における市場規模 - 心血管疾患における市場規模 - その他疾患における市場規模 ・世界のコンパニオン診断市場規模：エンドユーザー別 - 医薬品・バイオ医薬品企業における市場規模 - 参考検査室における市場規模 - 受託研究機関における市場規模 - その他エンドユーザーにおける市場規模 ・世界のコンパニオン診断市場規模：地域別 - 北米のコンパニオン診断市場規模 - アジアのコンパニオン診断市場規模 - 欧州のコンパニオン診断市場規模 - 中南米のコンパニオン診断市場規模 - 中東・アフリカのコンパニオン診断市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global companion diagnostics market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Companion diagnostics refer to a combination of tests and therapies that provide essential information about corresponding therapeutic products to deliver safe and effective medical care. These diagnostics also offer an in-depth understanding of disease biology and the mechanism of action (MOA), which help healthcare professionals determine the potential side effects or risks of a therapeutic product on the patient. At present, companion diagnostics are extensively utilized in oncology to deliver targeted therapies and personalized medicines to patients.
The growing prevalence of cancer, in confluence with the escalating demand for in-vitro diagnostics and targeted therapies, represents one of the key factors impelling the global companion diagnostics market growth. Apart from this, personalized healthcare (PHC) and precision medicine are also gaining traction in the treatment of cardiovascular, neurological, infectious and inflammatory diseases, which, in turn, is bolstering the growth of the market. Furthermore, the escalating demand for next-generation sequencing (NGS), the rising number of clinical trials and the increasing focus on the co-development of drugs and diagnostic technologies are contributing to the market growth. The introduction of new biomarkers, rising approvals of companion diagnostics and increasing collaboration between companies to develop novel companion diagnostic products are some of the other factors positively influencing the market growth. Currently, due to the spread of the coronavirus disease (COVID-19), diagnostic service providers are providing test services to healthcare providers. They are also utilizing companion diagnostics to detect the efficacy of COVID-19 drugs among patients undergoing oncology therapies.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global companion diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product & service, technology, indication and end user.
Breakup by Product & Service:
Assays, Kits and Reagents
Software and Services
Breakup by Technology:
Immunohistochemistry (IHC)
Polymerase Chain Reaction (PCR)
In-situ Hybridization (ISH)
Real-time PCR (RT-PCR)
Gene Sequencing
Others
Breakup by Indication:
Cancer
Lung Cancer
Breast Cancer
Colorectal Cancer
Gastric Cancer
Melanoma
Others
Neurological Diseases
Infectious Diseases
Cardiovascular Diseases
Others
Breakup by End User:
Pharmaceutical & Biopharmaceutical Companies
Reference Laboratories
Contract Research Organizations
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global companion diagnostics market in 2021?
2. What is the expected growth rate of the global companion diagnostics market during 2022-2027?
3. What has been the impact of COVID-19 on the global companion diagnostics market?
4. What are the key factors driving the global companion diagnostics market?
5. What is the breakup of the global companion diagnostics market based on the product & service?
6. What is the breakup of the global companion diagnostics market based on the technology?
7. What is the breakup of the global companion diagnostics market based on the indication?
8. What is the breakup of the global companion diagnostics market based on the end user?
9. What are the key regions in the global companion diagnostics market?
10. Who are the key players/companies in the global companion diagnostics market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Companion Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product & Service
6.1 Assays, Kits and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Software and Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Immunohistochemistry (IHC)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Polymerase Chain Reaction (PCR)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 In-situ Hybridization (ISH)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Real-time PCR (RT-PCR)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Gene Sequencing
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Indication
8.1 Cancer
8.1.1 Market Trends
8.1.2 Major Types
8.1.2.1 Lung Cancer
8.1.2.2 Breast Cancer
8.1.2.3 Colorectal Cancer
8.1.2.4 Gastric Cancer
8.1.2.5 Melanoma
8.1.2.6 Others
8.1.3 Market Forecast
8.2 Neurological Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cardiovascular Diseases
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical & Biopharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Reference Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Contract Research Organizations
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 BioMerieux
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Danaher Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Roche Holding AG
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 Myriad Genetics Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Siemens Healthcare
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Thermo Fisher Scientific Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
Figure 2: Global: Companion Diagnostics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Companion Diagnostics Market: Breakup by Product & Service (in %), 2021
Figure 4: Global: Companion Diagnostics Market: Breakup by Technology (in %), 2021
Figure 5: Global: Companion Diagnostics Market: Breakup by Indication (in %), 2021
Figure 6: Global: Companion Diagnostics Market: Breakup by End User (in %), 2021
Figure 7: Global: Companion Diagnostics Market: Breakup by Region (in %), 2021
Figure 8: Global: Companion Diagnostics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Companion Diagnostics (Assays, Kits and Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Companion Diagnostics (Assays, Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Companion Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Companion Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Companion Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Companion Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Companion Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Companion Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Companion Diagnostics (In-situ Hybridization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Companion Diagnostics (In-situ Hybridization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Companion Diagnostics (Real-time PCR) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Companion Diagnostics (Real-time PCR) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Companion Diagnostics (Gene Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Companion Diagnostics (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Companion Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Companion Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Companion Diagnostics (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Companion Diagnostics (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Companion Diagnostics (Neurological Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Companion Diagnostics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Companion Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Companion Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Companion Diagnostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Companion Diagnostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Companion Diagnostics (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Companion Diagnostics (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Companion Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Companion Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Companion Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Companion Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Companion Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Companion Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: North America: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: North America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Canada: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Canada: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Asia Pacific: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Asia Pacific: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: China: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: China: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: India: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: India: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: South Korea: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: South Korea: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Indonesia: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Indonesia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Europe: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Europe: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Germany: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Germany: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: France: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: France: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: United Kingdom: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: United Kingdom: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Italy: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Italy: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Spain: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Spain: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Russia: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Russia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Latin America: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Latin America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Brazil: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Brazil: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Mexico: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Mexico: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Middle East and Africa: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Middle East and Africa: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Global: Companion Diagnostics Industry: SWOT Analysis
Figure 92: Global: Companion Diagnostics Industry: Value Chain Analysis
Figure 93: Global: Companion Diagnostics Industry: Porter’s Five Forces Analysis
• 日本語訳：コンパニオン診断の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30134 ▷ お問い合わせ（見積依頼・ご注文・質問）